Author:
Shen Xiao-Li,Song Ning,Du Xi-Xun,Li Yong,Xie Jun-Xia,Jiang Hong
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Calsolaro, V. & Edison, P. Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer’s Disease and Other Neurodegenerative Diseases. CNS Drugs 29, 1023–1039 (2015).
2. St-Gelais, F., Jomphe, C. & Trudeau, L. E. The role of neurotensin in central nervous system pathophysiology: what is the evidence? J Psychiatry Neurosci 31, 229–245 (2006).
3. Tremblay, L. [Pathophysiology of Parkinson’s disease: an update]. Bull Acad Natl Med 194, 1321–1331, discussion 1331–1322 (2010).
4. Beitz, J. M. Parkinson’s disease: a review. Front Biosci (Schol Ed) 6, 65–74 (2014).
5. Klockgether, T. Parkinson’s disease: clinical aspects. Cell and tissue research 318, 115–120 (2004).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献